FDA Says Industry Has Work Left To Do To Make Antiviral Claims For Topicals
This article was originally published in The Rose Sheet
Executive Summary
FDA has rejected a citizen petition seeking antiviral labeling for OTC products covered by the Healthcare Antiseptic Drug Products monograph
You may also be interested in...
Has COVID Changed US FDA’s Thinking About OTC Antiseptics?
The public health emergency has shown that the US needs more hand sanitizers on store shelves, not less, right?
Rep. Markey Calls For Triclosan Ban, Galvanized By Sympathetic FDA Letter
Rep. Ed Markey, D-Mass., wants many personal-care applications of triclosan banned and is crafting chemicals safety legislation after receiving letters from FDA and EPA acknowledging that there are concerns about the ingredient
OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program